Rosuvastatin + Fenofibrate Interaction
Moderateinteraction on record
Description
No clinically significant increase in AUC observed, but risk of myopathy is increased with concomitant use of fenofibrates. Caution should be used.
Mechanism
Increased myopathy risk despite minimal pharmacokinetic interaction
Source: NLP:rosuvastatin